Brad Spellberg

professor, medicine, Harbor UCLA Medical Center

Dr. Spellberg is an Assistant Professor of Medicine at the David Geffen School of Medicine at UCLA, and is based in the Division of Infectious Diseases at Harbor-UCLA Medical Center. His promotion to Associate Professor will become effective July of 2009. He received his BA in Molecular Cell Biology- Immunology in 1994 from UC Berkeley. He then attended medical school at the Geffen School of Medicine at UCLA, where he received numerous academic honors, including serving as the UCLA AOA Chapter Co-President, and winning the prestigious Stafford Warren award for the topic academic performance in his graduating class. Dr. Spellberg completed his Residency in Internal Medicine and subspecialty fellowship in Infectious Diseases at Harbor-UCLA Medical Center, where he received the Department of Medicine Subspecialty Fellow of the Year award. He co-founded NovaDigm Therapeutics, Inc., a biotechnology company, to translate the vaccine from the bench to the bedside. Dr. Spellberg is also developing genetically engineered white blood cells that recapitulate neutrophil functions and can be used to overcome the technical barriers to neutrophil transfusion therapy for neutropenic infections. Finally, Dr. Spellberg established the first auditable, peer-reviewed dataset that confirms the decline in new antibiotic development over the last two decades, underscoring the need for development of new immune-based therapies for infections.